preliminary results
play

PRELIMINARY RESULTS Year ended 31 March 2010 2 June 2010 Agenda - PowerPoint PPT Presentation

PRELIMINARY RESULTS Year ended 31 March 2010 2 June 2010 Agenda Introduction Richard Moon Operational review Nick Jefferies Financial review Paul Neville Strategy and current trading Nick Jefferies 2 A year of change and


  1. PRELIMINARY RESULTS Year ended 31 March 2010 2 June 2010

  2. Agenda � Introduction Richard Moon � Operational review Nick Jefferies � Financial review Paul Neville � Strategy and current trading Nick Jefferies 2

  3. A year of change and progress � Trading improves with return to profitability and growth in order book � Acquisition of BFi Optilas completed and will achieve > £4.4m p.a. (€5m) operational savings � Specialisation strategy progressively implemented across Electronics division and repositions the Group � Supply Chain stable following acquisition of SSE � Strong net cash position of £13.9m at end of March 2010 � Maintained full year dividend of 7.0p (final 4.67p) 3

  4. Agenda � Introduction Richard Moon � Operational review Nick Jefferies � Financial review Paul Neville � Strategy and current trading Nick Jefferies 4

  5. Highlights � Second half much better than first half, return to profitability � Improving sales trends � Significant operational improvements � Positive operating cash flow, strong net cash position � BFi Optilas trading profitably from day one, integration proceeding well � Specialisation strategy making good progress � Continued trading improvement since the year end 5

  6. Improved operating performance Op Profit /Loss £m Sales £m � Return to profitability in second half � Recovery in volumes – 11% sequential (excluding BFi) � Benefit of cost savings made in H1 0.7 � Return to year on year growth � Group Orders increased 16% in March � Group Sales increased 6% in March � Customer order pipeline up 22% (Electronics) � BFi Optilas included for 4 months H2 2010 H1 2009 H2 2009 H1 2010 � Profitable from day one (£0.7m) � Sales of £30.5m Increasing sales, combined with decisive action to reduce operating expenses and working capital and increased gross margins, returns Group to profitability. Enhanced by BFi acquisition. 6

  7. Improved gross margins � Gross margin increased 1.1% points year-on- year � Underlying margin stable in second half � BFi enhances Group gross margin by c.0.2% � c.0.4% annualised � Specialisation strategy focuses on higher margin products 7

  8. Reduced operating expenses £m � Operating expenses reduced by 12% on comparable basis, £5.9m year-on-year � £1.1m associated exceptional cost � H2 operating expenses maintained at H1 level despite increased volumes � Further cost reductions underway in Supply Chain � BFi expenses of £8m for the 4 months � 13% reduction year-on-year 8 Note: Operating Expenses (adjusted) are at constant exchange rates and include SSE for comparable periods

  9. BFi Optilas integration proceeding to plan � Mid way through integration � Plan to complete by March 2011 � On track to achieve synergies p.a. > £4.4m (€5m), c.10% of combined cost base � Maintaining separate trading divisions � Acal Technology and BFi Optilas � Common warehouses, IT, F&A � Opportunities for additional revenue � Selective cross selling of product offer � Increased attractiveness to new suppliers 9 Includes BFi on a like for like basis

  10. Lower working capital £m � Working capital reduced by £10.1m, 38% since 31 March ’09 � Reduced to 12.7% as a percentage of sales (including acquisitions) � Operating cash flow before exceptional and pension payments positive £9.5m � Specialisation strategy reduces requirements for uncommitted inventory 10 Working capital defined as net inventory, trade debtors plus other receivables less trade payables and other payable

  11. Agenda � Introduction Richard Moon � Operational review Nick Jefferies � Financial review Paul Neville � Strategy and current trading Nick Jefferies 11

  12. Profit and Loss Account £m H1 FY10 H2 FY10 FY 10 FY09 Change � Operating performance (H2) Revenue - Sales improvement (+11%) - Existing 71.5 79.6 151.1 165.4 -8.6% - Gross margin improvement (+0.2pts) - Acquisition – BFi 30.5 30.5 71.5 110.1 181.6 165.4 +9.8% - Operating expense reduction Gross Margin 27.4% 27.6% 27.6% 26.5% +1.1% � Interest charge Operating (loss) / profit - H2 reduced to zero (1.7) 1.2 (0.5) 0.4 (adjusted) Exceptional items (0.4) (4.3) (4.7) (33.1) � Tax charge Finance (cost)/income - Small charge reflects profits in UK and (0.2) - (0.2) 0.5 (excluding IAS19) unrelieved losses in mainland Europe. (Loss) / profit before tax (1.9) 1.2 (0.7) 0.8 - £24m losses to c/fwd (adjusted) Loss before tax (2.7) (3.6) (6.3) (32.6) � EPS H2 to profit of 1.3p per share Taxation (0.1) (0.2) (0.3) (4.4) reducing loss for year to 8.2p per share � Dividend maintained at 7p per share Basic loss per share (9.5p) 1.3p (8.2p) (3.8p) excluding exceptional items Dividends per share relating 2.33p 4.67p 7.0p 7.0p to period 12

  13. Divisional results - sales � H2 on H1 sales increase excl BFi of 11.3% - Electronics 8% excl BFi £m H1 H2 Absolute Underlying FY10 FY10 FY10 FY09 Change Change - Supply Chain 12% - Medical 48% Electronics (Acal) 39.4 42.5 81.9 103.7 -21.0% -23.5% � Year on year underlying decline 16.3% BFi 30.5 30.5 Absolute decline 8.6% Electronics Total 39.4 73.0 112.4 103.7 FX impact 2.5% Supply Chain 29.2 32.8 62.0 54.2 14.4% -5.6% SSE acq’n in Jan 09 5.2% Medical 2.9 4.3 7.2 7.5 -4.0% -7.7% Underlying decline 16.3% Revenue 71.5 110.1 181.6 165.4 9.8% � Underlying revenue reflects: (reported) Electronics Revenue (exc. 71.5 79.6 151.1 165.4 -8.6% -16.3% - Market decline 16% BFi) H2 on H1 increase 11.3% - Loss of Linear Tech franchise 8% Supply Chain 6% Medical 8% 13

  14. Divisional results – adjusted operating profit £m H1 FY10 H2 FY10 FY10 FY09 � H2 operating profit of £1.2m reduces full year Electronics (Acal) (1.5) 0.6 (0.9) 0.9 operating loss to £0.5m - All divisions profitable in H2 BFi 0.7 0.7 Electronics Total (1.5) 1.3 (0.2) 0.9 � Electronics profit in H2 of £1.3m includes £0.7m BFi for 4 months - Sales in H2 increased 8% on H1 Supply Chain 0.6 0.6 1.2 1.1 - Opex reduced during year by £4.7m (18%) Medical 0.3 0.5 0.8 1.0 � Supply Chain profit up £0.1m - Underlying sales 6% down after adj for SSE acquisition in prior year Unallocated costs (1.1) (1.2) (2.3) (2.6) � Medical H2 improvement on H1 but delayed NHS expenditure gives lower full year result than prior year Adjusted operating (loss)/ profit (1.7) 1.2 (0.5) 0.4 14 Adjusted operating profit – operating profit before share-based payments, amortisation of intangible assets and exceptional items

  15. Exceptional operating items £m FY FY 2010 2009 Integration restructuring costs 2.4 - Other restructuring costs 1.9 2.6 Goodwill impairment 0.3 41.8 Sale of investment in MessageLabs 0.1 (15.9) Other - (0.8) Operating exceptionals 4.7 27.7 � Integration restructuring costs primarily relate to provision for closure of Netherlands warehouse and other office closures as well as certain termination costs -Total synergy savings forecast p.a. > £4.4m (€5m) � Other restructuring costs relate to; - Expense reductions £1.1m - Director terminations /other £0.8m � Goodwill relates to impairment of ATM Parts Company Ltd in Supply Chain division 15

  16. Balance sheet £m 31 March 31 March Var � Movements in net assets: £’m 2010 2009 Prop, plant & equip 3.9 4.7 (0.8) � Loss after tax (6.6) Intangible assets 16.5 15.0 1.5 � Translation differences (0.6) Working capital 30.8 26.7 4.1 � IAS 19 / LTIP (0.2) Tax (including deferred) (0.2) (2.6) 2.4 � Purchase of MI (0.4) Provisions (7.5) (4.0) (3.5) � New share capital 2.7 Pensions (5.5) (5.7) 0.2 � Dividends (1.6) Net cash 13.9 24.5 (10.6) (6.7) Net assets 51.9 58.6 (6.7) • Balance sheet reflects BFi acquisition and maintains strong net cash balance of £13.9m • Working capital – underlying reduction (31 March 2010 includes £14m for BFi) • Provisions include certain synergy provisions for exceptional costs 16

  17. Pension Update � IAS 19 pension liability £5.5 million (31 March 09: £5.7 million) � Update on Fund Actuarial Valuation � Triennial actuarial valuation at Dec 2009 agreed at £11.2m deficit (previous estimate £15m) � New funding from 1 April 2010 - for two years at reduced 50% rate of £0.65m from 1 April 2010 - followed by further 10 years starting at £1.5m indexed by 3% p.a. to £2.0m for y/e 2022 17

  18. Working capital balances � Working capital - Underlying reduction of £8.6m (32%) Working Capital as % of sales � Inventories - £8.0m (32%) reduction since 31 March 09 - Electronics reduced by 48% since 1 Jan 09 - Turns increased from 5.3 to 7.5 � Receivables - Group Days Sales Outstanding maintained at 51 days -Excluding BFi reduced by 5 days to 46 days � Working capital as % of sales - Including BFi annualised is12.7% due to larger European debtors 18

  19. Movement in net cash Underlying £m FY10 FY10 FY09 Operational cash flow 5.2 8.2 (2.4) Capital expenditure less disposals 0.3 (0.8) (1.2) Proceeds from sale of investments 1.0 - 15.1 Acquisitions (11.7) - (4.4) Interest (net)/associate dividends (0.2) (0.2) 0.8 Dividends paid (1.6) (2.0) (4.8) Tax (3.1) (0.7) (3.4) Net cash flow (10.1) 4.5 (0.3) Exchange /other 0.5 (0.8) Debt acquired (1.0) - Net cash movement (10.6) (1.1) Opening cash 24.5 25.8 Net cash at 31 March 13.9 24.5 � Underlying net cash flow before exceptionals positive of £4.5m 19

Recommend


More recommend